Clinical Implication of Multi-Parameter Flow Cytometry in Myelodysplastic Syndromes.

ABSTRACT: Myelodysplastic syndromes (MDS) are a challenging group of diseases for clinicians and researchers, as both disease course and pathobiology are highly heterogeneous. In (suspected) MDS patients, multi-parameter flow cytometry can aid in establishing diagnosis, risk stratification and choice of therapy. This review addresses the developments and future directions of multi-parameter flow cytometry scores in MDS. Additionally, we propose an integrated diagnostic algorithm for suspected MDS.

SUBMITTER: Duetz C 

PROVIDER: S-EPMC6482988 | biostudies-literature |

REPOSITORIES: biostudies-literature